Inhalation Digital Issue Now Available
photoNew at Respiratory Drug Delivery (RDD™) 2018
Respiratory Drug Delivery (RDD™) 2018 will be held April 22-26 at the JW Marriott Starr Pass Resort & Spa in Tucson, Arizona, US. As of March 6, the following companies, who have recently advertised in Inhalation, were listed on the conference website as exhibitors. Additional exhibitors are added continually. Content is provided by the companies listed.
No product endorsement or preference is intended.
Aptar Pharma
Aptar Pharma is pleased to be a Platinum Sponsor at RDD 2018. Their experts will host an interactive table showcasing Aptar Pharma's innovative range of MDIs, DPIs, BAIs and next generation e-Devices demonstrating how Aptar Pharma can accelerate customers' speed-to-market. Aptar Pharma experts will present a 40-minute talk, "Decoding FDA's Recent Combination Drug Product Guidance: Applications to DPIs, pMDIs and Nasal Sprays" on April 24 at 8:00 am and 8:45 am in Tucson Room I and J.
France: +33 1 39 17 20 20
Astech Projects, Ltd.
Astech Projects specializes in the supply of automated inhaler testing solutions for all device types including DPI, MDI and BAI. Astech's award-winning X-Products® range, which includes Xelair®, Xelize® and Xelox®, provides robust, durable and consistent testing for Dose Content Uniformity (DCU) and Particle Size Determination (PSD) including Andersen and NGI Impactors. Custom automated solutions are available for waste firing, physical device testing, emitted dose weight, vision and inspection. Astech also offers a comprehensive maintenance and support service called REACTS®, providing peace of mind for the lifetime of a system.
UK: +44 1928 571797
Lonza Pharma & Biotech has extensive particle engineering expertise and capabilities for dry powder inhalation (DPI) applications based on either micronization or spray drying technology, including phase-appropriate encapsulation from early formulation design through to late-stage clinical and commercial scale. Lonza Pharma & Biotech can support end-to-end product development through an extensive offer of both HPMC and gelatin specialized Capsugel® DPI capsules, designed specifically for inhalation applications.
US: +1 888 783-6361
At RDD 2018, Catalent will be showcasing its solutions in the development of inhalation and nasal drug products. Catalent's formulation expertise and experience have been successfully applied to multiple dosage forms, as have Catalent Micron Technology's particle-size engineering capabilities, which can work to the most stringent specifications demanded by inhalation formulators. Catalent's inhalation manufacturing operations have a track record of regulatory excellence and they routinely manufacture pMDIs, DPIs and nasal formulations for customers around the globe.
Copley Scientific
Copley Scientific will launch new equipment to meet the requirements of the recently proposed draft US Pharmacopoeia (USP) Monograph for Albuterol Inhalation Aerosols, along with an accessory that allows the use of existing mouthpiece adapters, to simplify interfacing the inhaler with the induction port. At the same time, the new TPK™ 2100 Critical Flow Controller, a highly automated unit for reproducible, cost-efficient, dry powder inhaler (DPI) testing, will also make its US debut at RDD 2018.
UK: +44 1159 616229
Gateway Analytical
Gateway Analytical is a cGMP-compliant laboratory with ISO 9001 and ISO 17025 accreditations that provides industry-leading pharmaceutical analysis services tailored to support unique drug development projects. Our pharmaceutical analysis services provide support for your company at all stages of development, from preclinical decisions to post-market regulatory inquiries. Learn more by attending our scientific poster session, "Analysis of a Dry Powder Inhaler (DPI) Using Scanning Electron Microscopy."
US: +1 724 443-1900
H&T Presspart
H&T Presspart's eMDI™ is a market-ready, fully embedded and connected metered dose inhaler, tracking and recording data on the use of medications, and sharing it with patients and physicians via a mobile or web app. The eMDI™ integrates with Cohero Health's BreathSmart™ disease management platform, and improves patients' adherence to medication doses, encourages self-care and helps health professionals maintain real-time monitoring.
UK: +44 1254 584131
Hovione offers development and compliant manufacture of innovative new drugs and niche generic active pharmaceutical ingredient (API) products. Hovione also supports highly potent compounds and offers proprietary product development and licensing opportunities for drug products. The company undertakes formulation development and clinical supply of final dosage forms to Phase II. With strong expertise in pulmonary delivery, Hovione also offers APIs for inhala tion, DPI devices and particle engineering services.
Portugal: +351 21 982 9000
Meggle Excipients & Technology
Meggle Excipients & Technology is a global leader in manufacturing lactose for the pharmaceutical industry. Meggle is at the forefront of lactose qualities for dry powder inhalation. Through precise product design, Meggle has developed the highly functional product family InhaLac®, which possesses unique features for the formulation of orally inhaled and nasal drug products. Several sieved and milled grades are obtained through tightly controlled production processes.
Germany: +49 08071 73 476
Merxin is a generic medical device company that supplies inhalation devices "off the shelf and ready to use," including a generic blister DPI for fluticasone and salmeterol, generic capsule DPI for tiotropium and generic soft mist inhaler for tiotropium, olodaterol and combinations. Merxin also supports its clients to accelerate the filing of inhaled finished dosage forms based on its device platforms, assisting with human factor studies, peak inspiratory flow studies, leachable and extractables studies, CE marking, integration of the formulation in the devices and full regulatory support.
UK: +44 1223 787300
MSP Corporation
MSP offers a comprehensive line of qualification services for inhaler testing equipment. As a trusted leading supplier of DDU and PSD testing equipment, MSP's qualification service offerings are also value-added. At competitive prices, cascade impactors (all types) and their accessories, flow meters, flow controllers, leak testers, and all inhaler testing instrumentation are qualified and returned to MSP's customers in 10 business days or less, with on-site services also available upon request. MSP is committed to helping its customers maintain the quality of their inhaler testing equipment, enabling the highest levels of productivity.
US: +1 651 287-8100
Next Breath
Next Breath is a full-service, cGMP-compliant laboratory specializing in the analytical testing of drug delivery systems. We provide comprehensive solutions for the product development process, from formulation and CMC support to finished batch release and post-approval stability studies.
US: +1 410 455-5904
Proveris Scientific
At RDD 2018, Proveris Scientific will demonstrate their new Kinaero™ High-Throughput Fire Down System. A team of experts will be on-hand at the technology exhibition to discuss how Proveris' testing instruments increase pMDI testing efficiency in product development and QC workflows. They will also present research on "The Impact of Actuator Design on Multi-Dose Nasal Spray Characteristics" in the scientific poster session.
US: +1 508 460-8822
Qualicaps® specializes in two-piece capsules, the delivery system of choice for pharmaceutical dosage forms for more than a century. Their corporate website is designed and developed to enhance user experience by providing a more interactive interface and easy-to-access information about the company, its capsules and related equipment. It has a detailed menu for friendly and rapid navigation, downloadable materials and is available in multiple languages.
US: +1 336 449-3783
Following a $750K investment, Recipharm has opened a GMP suite for clinical trial material (CTM) manufacture at its facility in Research Triangle Park, North Carolina. The suite can produce CTM for clinical studies up to Phase II for non-sterile dosage forms, including metered dose inhalers. The team at RTP can provide specialized formulation and characterization expertise and offers complete early-phase development services, from process development and scale-up to CTM manufacturing and packaging, product release and stability programs.
US: +1 919 884-2064
RDD Online
RDD Online is the sole supplier of Virginia Commonwealth University Realistic Mouth-Throat Models in three sizes, and the patented Nephele Mixing Inlet for use with ACI or NGI. These inhaler-testing tools allow representative oropharyngeal capture and APSD to be measured under simulated breathing conditions. We also supply EP- and USP-compliant MDI and DPI Dosage Unit Sampling Apparatus (DUSAs) kits. In addition, our table is a great place to learn about RDD Asia 2018 in India and RDD Europe 2019 in Portugal.
US: +1 804 827-1490
Fusion Inhaler Testing (FIT) is a complete and automated software for respiratory drug product testing–scalable from standalone to enterprise. It fully supports Part 11 Compliance and contains an integrated workflow management system with custom templating. FIT supports USP Apparatuses 1–6, Ph.Eur. Apparatuses C, D, E, FSIs, FSAs and DUSAs, meets all PSD calculation and reporting requirements for USP <601> and Ph. Eur. 2.9.18, and contains closed-loop automated HPLC testing via ChemStation, Chromeleon and Empower.
US: +1 707 441-0404
Inhalation Magazine •
Copyright 2018, CSC Publishing Inc. All Rights Reserved • Privacy policy